Clinical Trials
62 trialsCost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Eastern Cooperative Oncology Group
ICE COMPRESS
SWOG Cancer Research Network
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
SWOG Cancer Research Network
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
SWOG Cancer Research Network
Quality of End-of-Life Care for Children With Cancer
Children's Oncology Group
MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
Canadian Cancer Trials Group
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Children's Oncology Group
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Children's Oncology Group
PREDIR
Fondation Ophtalmologique Adolphe de Rothschild
NEMO
European Organisation for Research and Treatment of Cancer - EORTC
SPECTAlung
European Organisation for Research and Treatment of Cancer - EORTC
Collecting and Storing Tissue From Young Patients With Cancer
Children's Oncology Group
Spine-SABR
Cancer Trials Ireland
DC-CTL
Zhengzhou Revo-Gene Technology Co., LTD
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
NIMBLe
Canadian Cancer Trials Group
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
Canadian Cancer Trials Group
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Canadian Cancer Trials Group
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Canadian Cancer Trials Group
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Eastern Cooperative Oncology Group
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
European Organisation for Research and Treatment of Cancer - EORTC
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
Children's Oncology Group
Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
MG98 in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
Theophylline in Treating Cancer Patients With Shortness of Breath
Canadian Cancer Trials Group
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
SWOG Cancer Research Network
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
Children's Oncology Group
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia
Fondation Ophtalmologique Adolphe de Rothschild
EUS-FNA for Patients With Antithrombotic Agents
Hokkaido Pancreatobiliary Endoscopic Intervention Study Group
S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors
SWOG Cancer Research Network
Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation
The Korean Society of Pediatric Hematology Oncology
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Cancer Trials Ireland
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
Children's Oncology Group
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Children's Oncology Group
Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
Children's Oncology Group
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
Children's Oncology Group
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Children's Oncology Group
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
California Cancer Consortium
Registration and Informed Consent Study for the Childhood Cancer Research Network
Children's Oncology Group
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
SWOG Cancer Research Network
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
European Organisation for Research and Treatment of Cancer - EORTC
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
European Organisation for Research and Treatment of Cancer - EORTC
Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC